Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Hypera S.A. HYPMY OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • BR • USD

SharesGrow Score
60/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Hypera S.A. (HYPMY) — Analyst outlook / Analyst consensus target is. Based on 1 analyst ratings, the consensus is neutral — 1 Hold.

HYPMY Analyst Ratings

Hold
1
Ratings
1 Hold
Based on 1 analysts giving stock ratings to Hypera S.A. in the past 3 months
Rating breakdown
Hold
1 100%
0%
Buy
0 analysts
100%
Hold
1 analysts
0%
Sell
0 analysts

People Also View

DNPUF
DNPUF
Sumitomo Pharma Co., Ltd.
$11.11
+0.00%
 IZQVF
IZQVF
Indivior PLC
$20.97
+0.00%
 CPIX
CPIX
Cumberland Pharmaceuticals Inc.
$3.20
+0.63%
 RAMMF
RAMMF
RAMM Pharma Corp.
$0.06
+0.00%
 PHCG
PHCG
Pure Harvest Corporate Group, Inc.
$0.01
+4.00%
 CVGRF
CVGRF
City View Green Holdings Inc.
$0.03
-4.57%
 YOURF
YOURF
YourWay Cannabis Brands Inc.
$0.00
+0.00%
 SPBBF
SPBBF
Speakeasy Cannabis Club Ltd.
$0.00
+0.00%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message